Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics

Project Title Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics
Date
Monday, October 6, 2014
Location
Description

This article describes the findings of a study conducted to evaluate baseline glucose assessment among youth ages 2 through 18 starting a second-generation antipsychotic in the United States.

Medical Product
aripiprazole
olanzapine
quetiapine
risperidone
second generation antipsychotic (SGA)
Health Outcome
baseline glucose assessment
Population / Cohort
All children 2 through 18 years of age
Time Period
2006 - 2011
Corresponding Author

Marsha Raebel, Institute for Health Research, Kaiser Permanente Colorado, PO Box 378066, Denver, CO 80237, USA. Email: Marsha.A.Raebel@kp.org

Authors

Marsha Raebel PharmD; Robert Penfold PhD; Ann McMahon MD, MSc; Marsha Reichman PhD; Susan Shetterly MS; Glenn Goodrich MS; Susan Andrade ScD; Christoph Correll MD; Tobias Gerhard PhD

Data Sources
Mini-Sentinel Distributed Database (MSDD)
Related Links